Differences in mRNA Expression of Selected Cytochrome P450, Transporters and Nuclear Receptors Among Various Rat Models of Metabolic Syndrome
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Jan Soukop und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology at the Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Metabolic Syndrome, RNA, Messenger, Receptors, Cytoplasmic and Nuclear, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Palacky University Olomouc, Ministry of Health of the Czech Republic, Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
Metabolic syndrome (MetS) is a cluster of risk factors that increase the likelihood of developing cardiovascular, metabolic and other diseases. The pharmacological management of MetS often involves polypharmacy, making it essential to understand how drug‐metabolising enzymes, transporters, transcription factors and other proteins involved are affected under different metabolic conditions. This study investigated the relative mRNA expression of key hepatic and intestinal genes involved in drug metabolism, including Cyp1a2 , Cyp3a23 , Cyp2d1 , Cyp2c11 , Cyp2c6 , Cyp2e1 , Cyp7a1 , Cyp2b1 , Cyp2a1 , Abcg5 , Abcg8 , Abcb1 , Nr1i3 , Nr1i2 , Ahr , Gsta1 and Comt , in four nonobese rat models of MetS: hereditary hypertriglyceridaemic (HHTg), spontaneously hypertensive rat (SHR), SHR expressing transgenic human C‐reactive protein (SHR‐CRP), and bilaterally ovariectomised Wistar (W‐OVX), compared to Wistar controls. Gene expression was quantified by RT–PCR with data normalised using the ΔΔ Ct method. Between the models studied, measurements showed significant differences in the liver. The upregulation of Cyp2c6 and Cyp3a23 was observed only in SHR; upregulated Cyp2d1 was found in SHR as well as in HHTg rats. The downregulated Cyp1a2 was measured in a condition of hypertriglyceridemia, postmenopause or hypertension. These findings highlight model‐specific alterations in gene expression that may affect drug metabolism and interactions. The HHTg may be, in particular, a suitable model for preclinical studies focusing on intestinal drug–drug interactions in MetS‐related conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology at the Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
- Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Department of Microbiology at the Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
ORCID-Profile: Jan Soukop
Förderung
- Palacky University Olomouc
- Ministry of Health of the Czech Republic
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Soukop, J., Rácová, Z., Kazdová, L., Zapletalová, I., Poruba, M., Malínská, H., Hüttl, M., Marková, I., Nováková, K., & Večeřa, R. (2025). Differences in mRNA Expression of Selected Cytochrome P450, Transporters and Nuclear Receptors Among Various Rat Models of Metabolic Syndrome. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70075
Vancouver
Soukop J, Rácová Z, Kazdová L, Zapletalová I, Poruba M, Malínská H, et al. Differences in mRNA Expression of Selected Cytochrome P450, Transporters and Nuclear Receptors Among Various Rat Models of Metabolic Syndrome. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70075
BibTeX
@article{Soukop2025,
author = {Soukop, Jan and Rácová, Zuzana and Kazdová, Ludmila and Zapletalová, Iveta and Poruba, Martin and Malínská, Hana and Hüttl, Martina and Marková, Irena and Nováková, Kristýna and Večeřa, Rostislav},
title = {Differences in mRNA Expression of Selected Cytochrome P450, Transporters and Nuclear Receptors Among Various Rat Models of Metabolic Syndrome},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70075}
}
EUVIMED